Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer

HIGHLIGHTS

• What: The aim of this work is the synthesis of a new type of PMO, Mesoporous Organosilica Drugs (MODs), made up of the chemotherapeutic drug MTO. The aim in the design of MODs was to synthesize a bis-organosilane derivative of the drug MTO that could be used as a bridged silica precursor for the synthesis of MODs.
• Who: Magnetically modified-mitoxantrone and collaborators from the (UNIVERSITY) have published the article: RESEARCH Open Access, in the Journal: (JOURNAL)

SUMMARY

Particularly interesting are MSNs ranging from 10 to 200 nm because they . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.